Top 10 Books about Stock Investing to read in 2018. Read more.

BSPM - Biostar Pharmaceuticals

Industry: Drug Manufacturers - Major Sector: Healthcare Exchange: NASDAQ

BSPM - Biostar Pharmaceuticals

Industry: Drug Manufacturers - Major Sector: Healthcare Exchange: NASDAQ
#4387()/6583

Fri 25'th May 2018

PERIOD 2018-02-26 - 2018-05-25
CHANGE 0.00%
PRICE $2.37
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Buy

MACD
Buy

Request Prediction
0.00%
Predict

Biostar Pharmaceuticals Stock Analysis

Technical stock analysis for Fri 25'th May 2018

Sell candidate since 2018-05-24

No changes to the price of Biostar Pharmaceuticals in the last trading day. The price has fallen in 5 of the last 10 days and is down by -8.14% for this period.

Shorts 2.23% ( 2018-04-30 )
Cash n/a
Loans n/a
Beta 2.40
ROA 2.23

Trend

Biostar Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -30.77% during the next 3 months and, with 90% probability hold a price between $1.11 and $2.12 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Thursday May 24, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Biostar Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.45 and $2.58. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 31 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $2.22 and $2.20.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Biostar Pharmaceuticals finds support just below today's level at $2.22. If this is broken, then the next support from accumulated volume will be at $2.20 and $2.02.

Support: $2.22 Price: $2.37 Resistance: $2.68

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.16 between high and low, or 6.81%. For the last week the stock has had a daily average volatility of 5.44%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

Biostar Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Trade BSPM CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

START FREE 5-DAY TRIAL